European paediatric non-alcoholic fatty liver disease registry (EU-PNAFLD): Design and rationale

Jake P. Mann, Anita Vreugdenhil, Piotr Soch, Wojciech Jariczyk, Ulrich Baumann, Sanjay Rajwal, Thomas Casswall, Claude Marcus, Indra van Mourik, Stephen O'Rahilly, David B. Savage, Gabriele Noble-Jamieson, Florence Lacaille, Myriam Dabbas, Beatrice Dubern, Deirdre A. Kelly, Valerio Nobili, Quentin M. Anstee

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)67-71
Number of pages5
JournalContemporary Clinical Trials
Volume75
DOIs
Publication statusPublished - 1 Dec 2018

Keywords

  • Fatty liver
  • Cirrhosis
  • Natural history
  • Exome sequencing
  • Biomarkers
  • CONFERS SUSCEPTIBILITY
  • ADVANCED FIBROSIS
  • YOUNG-ADULTS
  • CHILDREN
  • NAFLD
  • RISK
  • ADOLESCENTS
  • VARIANT
  • STEATOHEPATITIS
  • PREVALENCE

Cite this

Mann, J. P., Vreugdenhil, A., Soch, P., Jariczyk, W., Baumann, U., Rajwal, S., Casswall, T., Marcus, C., van Mourik, I., O'Rahilly, S., Savage, D. B., Noble-Jamieson, G., Lacaille, F., Dabbas, M., Dubern, B., Kelly, D. A., Nobili, V., & Anstee, Q. M. (2018). European paediatric non-alcoholic fatty liver disease registry (EU-PNAFLD): Design and rationale. Contemporary Clinical Trials, 75, 67-71. https://doi.org/10.1016/j.cct.2018.11.003